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Abstract: The inﬂ  uence of diesel exhaust particles (DEP) on the lungs and heart is currently 
a topic of great interest in inhalation toxicology. Epidemiological data and animal studies 
have implicated airborne particulate matter and DEP in increased morbidity and mortality due 
to a number of cardiopulmonary diseases including asthma, chronic obstructive pulmonary 
disorder, and lung cancer. The pathogeneses of these diseases are being studied using animal 
models and cell culture techniques. Real-time exposures to freshly combusted diesel fuel are 
complex and require signiﬁ  cant infrastructure including engine operations, dilution air, and 
monitoring and control of gases. A method of generating DEP aerosols from a bulk source in an 
aerodynamic size range similar to atmospheric DEP would be a desirable and useful alternative. 
Metered dose inhaler technology was adopted to generate aerosols from suspensions of DEP in 
the propellant hydroﬂ  uoroalkane 134a. Inertial impaction data indicated that the particle size 
distributions of the generated aerosols were trimodal, with count median aerodynamic diameters 
less than 100 nm. Scanning electron microscopy of deposited particles showed tightly aggre-
gated particles, as would be expected from an evaporative process. Chemical analysis indicated 
that there were no major changes in the mass proportion of 2 speciﬁ  c aromatic hydrocarbons 
(benzo[a]pyrene and benzo[k]ﬂ  uoranthene) in the particles resulting from the aerosolization 
process.
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Introduction
Chronic and acute exposure to airborne particulate matter (PM) and diesel exhaust 
particles (DEP) have been identiﬁ  ed as human health hazards. Cohort epidemiologic 
studies have indicated that chronic exposure to PM is a likely risk factor in the formation 
of lung cancer as well as a potential noncancerous respiratory hazard (Pope et al 
2002). Time series studies have shown that short term increases in levels of PM are 
associated with increased mortality and morbidity (Bell et al 2004). DEP are a likely 
contributor to the acute and chronic toxicity of inhaled PM and are a major component 
of ambient PM. DEP makes up approximately 6% of nationwide ambient PM2.5 mass 
and considerably more in some urban areas (USEPA 2002). The extent of the DEP 
contribution to PM toxicity is not known because it is difﬁ  cult to isolate the effects 
of exposure to diesel exhaust (DE) or DEP in humans. Some epidemiology studies 
involving groups of individuals exposed to elevated levels of DEP in the workplace 
have shown increases in relative risks of lung cancer and respiratory disease (Bhatia 
et al 1998; Lipsett and Campleman 1999; Sauvain et al 2003). Some indication of 
decreased pulmonary function (Gamble et al 1987) and increased mortality from 
cardiovascular disease (Edling and Axelson 1984) has also been noted in chronically 
exposed workers. A few studies have shown that short term pulmonary exposure to International Journal of Nanomedicine 2008:3(4) 436
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DE or DEP elicits an inﬂ  ammatory response, marked by 
an increase in neutrophils and/or interleukin-8 (IL-8) in 
bronchoalveolar lavage ﬂ  uid, in healthy volunteers (Rudell 
et al 1999; Salvi et al 1999; Salvi et al 2000). The majority 
of evidence for DEP-speciﬁ  c toxicity, however, comes from 
animal experimentation.
Animal experiments allow the study of effects of DEP 
exposure, which, with in vitro toxicology, elucidates the 
pathogenesis of disease following exposure. Chronic DE 
and DEP exposure affects laboratory animals by changing 
survival, pulmonary function, inﬂ  ammation, histopathology, 
and cancer rates (Vinegar et al 1981; Lewis et al 1986; 
Iwai et al 1986; Henderson et al 1988; Nikula et al 1995). 
Pulmonary inﬂ  ammation following acute exposure in animals 
has been repeatedly observed (Yang et al 1999; Nemmar 
et al 2003; Harrod et al 2003). A large number of in vitro 
studies have been conducted using various cells types to 
determine the cellular response to exposure to DEP and their 
components (Bayram et al 1998; Hiura et al 1999; Takizawa 
et al 1999, 2003; Don Porto Carero et al 2001; Li et al 2002; 
Amakawa et al 2003; Auferhide et al 2003; Baulig et al 
2003). There are many questions and concerns, however, 
when drawing conclusions about the toxicity of a material in 
humans from exposure studies conducted in animals or cells. 
These concerns are ampliﬁ  ed for a heterogeneous, inhaled 
toxicant, such as DEP, because of the complicated interac-
tion between particle properties, deposition, and toxicity. 
The methods currently employed of assessing pulmonary 
toxicity of DEP in animals or cells in culture may not be 
representative of particles inhaled by humans.
DEP are often delivered to the lungs of animals as 
aqueous liquid instillations and the prevalent methodology 
for exposing cells is to spike an aqueous suspension of DEP 
at the apical surface of cells. Delivery of particles in aqueous 
suspension alters the particles themselves and the manner 
in which they are presented to the cells of the lung. These 
methods may be acceptable to identify certain potential 
mechanisms for DEP toxicity in the lung, but do not address 
issues speciﬁ  c to atmospheric DEP such as particle size and 
the interaction between insoluble and soluble compounds.
The deposition of particles in the lung is highly dependant 
on the properties of the particles. Particle size, speciﬁ  cally 
aerodynamic diameter, is of primary importance in the 
determination of probability and location of deposition 
of a particle in the lungs. DEP exist in the atmosphere in 
a trimodal size distribution with aerodynamic diameters 
ranging from 10 nm to more than 1 μm (Kittelson 1998). 
This size distribution makes them easily respirable and 
likely to deposit throughout the lungs (ICRP 1994). The 
nuclei mode (5–50 nm), containing droplets of organic and 
sulfur compounds and, potentially, solid carbon and metal 
particles, comprises a small fraction of the DEP mass, but 
the numerical majority of particles. The accumulation mode 
(100–1000 nm), consisting of aggregates of solid carbon par-
ticles with a number of adsorbed organic compounds, salts, 
and trace elements on the surface, makes up the majority of 
DEP mass. The coarse mode, comprised of larger aggregates 
(1–10 μm), is generally not signiﬁ  cant in terms of number or 
mass. This size distribution needs to be reproduced in the lab 
in order to obtain realistic lung deposition patterns.
The organic compounds, averaging 20% to 40% of total 
mass for most DEP (USEPA 2002), are thought to be pri-
marily responsible for the cancer and noncancer toxicity of 
DEP. The hundreds of compounds adsorbed to the surface 
of the solid carbon particles include at least 15 polyaromatic 
hydrocarbons (PAHs) or nitro-polyaromatic hydrocarbons 
(N-PAHs) that are considered to be potential or probable 
carcinogens by the US National Toxicology Program 
(Sauvain et al 2003). Their metabolism causes production 
of reactive oxygen species (ROS), which can be directly 
toxic by damaging lipids, proteins, and DNA, and can elicit 
an inﬂ  ammatory response. All of these mechanisms require 
interaction with the particles and are therefore dependent 
on the surface properties of those particles, which may be 
altered by suspension in liquid.
The limitations of employing DEP suspensions have 
been identiﬁ  ed and a number of systems to expose animals 
and cultured cells to freshly generated DE and DEP 
have been developed (Massey et al 1998; Wolz et al 2002). 
These methods represent a realistic deposition scenario, 
but have several major drawbacks. The systems employed 
require considerable space, money, and time to set up, 
operate, and maintain. Freshly generated DEP may not 
represent atmospheric DEP because effects of aging are not 
taken into account. Due to the complexity of the combustion 
process, engine-based exposure systems inevitably lead 
to inter-laboratory variability in the particles produced. 
Regeneration of DEP aerosols from small quantities of bulk 
powder in particle sizes relevant to atmospheric pollution 
for laboratory testing is a desirable technique to develop. 
A low dose delivery approach would allow deposition of 
particles in a realistic size range, and aerosols with the same 
properties could be generated in multiple locations following 
distribution of samples from a single bulk source.
When collected by ﬁ  ltration and stored in a sealed vessel, 
DEP are forced into close contact with each other, promoting International Journal of Nanomedicine 2008:3(4) 437
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aggregation. The production of aerosols with a small average 
particle diameter from an aggregated powder is not easily 
accomplished. Some devices, including the Wright dust 
feeder and ﬂ  uidized bed generators, generate aerosols from 
a bulk source of powder (Hinds 1999). These devices require 
relatively large volumes of bulk powder and are not design 
for generating single small doses of aerosol. The creation of 
aerosols with small particle sizes from small quantities of 
powder has been an aim of the pharmaceutical industry for 
years. Metered dose inhalers (MDIs) are used in the pharma-
ceutical industry to deliver aerosols by inhalation (Atkins and 
Crowder 2004). Suspension MDIs allow de-aggregation of a 
powder in an inert liquid propellant. Following aerosoliza-
tion, the propellant evaporates, leaving only the suspended 
particles. The size of the resultant particles can be modulated 
by controlling the suspension concentration, initial droplet 
size, and level of de-aggregation in the suspension.
This study provides a characterization of DEP aerosols 
generated in small doses from a bulk source using the 
principals of metered dose inhaler technology. The mass and 
number-based aerodynamic particle size distributions of the 
aerosols were determined by cascade impaction, the physical 
size and morphology of deposited particles were examined 
by scanning electron microscopy (SEM), and a preliminary 
chemical analysis comparing pre- and post-aerosolized DEP 
is presented.
Materials and methods
Sources of diesel exhaust particles
DEP were generated at the EPA main campus in Research 
Triangle Park, North Carolina using a 30 kW (40 hp) 
4-cylinder Deutz BF4M1008 diesel engine connected to 
a 22.3 kW Saylor Bell air compressor to provide a load. 
The engine and compressor were operated at steady-state to 
produce 0.8 m3/min of compressed air at 400 kPa. This 
translates to approximately 20% of the engine’s full-load 
rating. Emissions from the engine were diluted with ﬁ  ltered 
air (3:1) to near ambient temperatures (∼35 °C) and directed 
to a small baghouse (Dustex Model T6-3.5-9 150 ACFM 
pyramidal baghouse using nine polyester felt bags). Gram 
quantities of DEP were collected using reverse air pulsing. 
Once collected, the DEP samples were stored in sealed glass 
containers in a refrigerator (∼4 °C).
DEP quantiﬁ  cation
For the preparation of turbidity concentration curves, DEP 
were suspended in ethanol, placed in an ultrasonic bath 
(FS21H; Fisher Scientiﬁ  c, Pittsburgh, PA, USA) for 30 s, 
serially diluted, and sonicated again brieﬂ  y before reading 
light extinction at 700 nm (EXT700) (UV160U spectropho-
tometer; Shimadzu). To determine the effect of sonication 
time on EXT700, suspensions of DEP in ethanol (7.95 μg/ml) 
were placed in a sonication water bath (Model 2510; Branson, 
Danbury, CT, USA) for 30, 60, or 180 seconds with swirling 
every 15 seconds. The suspensions were removed from 
the bath, swirled, and EXT700 was measured (Libra S22; 
Biochrom, Cambridge, UK).
Suspension preparation
DEP was added to plastic-coated clear glass bottles (Wheaton 
Science Products, Millville, NJ, USA) ﬁ  tted with 25 μl 
metering valves (Bespak, Apex, NC, USA) that were sealed 
by crimping (Aero-Tech Laboratory Equipment Company, 
Worcester, NY, USA). Prior to ﬁ  tting, holes that connected 
the valve stem to the bottle during actuation were drilled in 
some of the metering valves, creating nonmetered, continuous 
valves. The bottles were then ﬁ  lled with 20 g of HFA134a 
(hydroﬂ  uoroalkane 134a) through the valve using a pressure 
burette (Aero-Tech) at 175 PSI. The resultant suspensions 
(0.2, 1.0, and 5.0 mg DEP/g HFA134a) were placed in an 
ultrasonic bath for 10 minutes to disperse the particles. All 
aerosols were generated using an actuator with a 300 μm 
diameter round oriﬁ  ce.
Suspension stability
Stability of 0.2, 1.0, and 5.0 mg/g suspensions was estimated 
by observing aggregation and sedimentation of the suspended 
particles as functions of time following 10 seconds of 
vigorous vortex mixing (Vortex Genie 2; Fisher Scientiﬁ  c). 
The general appearance of the suspension (opacity, formation 
of large aggregates, and/or sedimentation) was monitored 
in the ﬁ  rst 5 minutes following mixing. If the particles 
sedimented as a single, aggregated mass, the time it took 
for the top of the aggregate to sediment to speciﬁ  c heights 
(5 mm apart) was recorded (n = 3 for each of 3 bottles for 
each concentration). The relative concentrations of sus-
pended DEP were estimated by measuring EXT700 (UV160U) 
through the glass bottles from 5 to 80 minutes following 
mixing (n = 3 for each of 3 bottles for each concentration). 
For EXT700 measurements, the bottles were centered between 
the light source and detector of the spectrophotometer. Sus-
pensions were also observed 24 hours after mixing.
Emitted dose
The emitted doses for 0.2, 1.0, and 5.0 mg/g suspensions in 
bottles ﬁ  tted with 25 μl metered valves and for a 1.0 mg/g International Journal of Nanomedicine 2008:3(4) 438
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suspension ﬁ  tted with a continuous valve were determined 
by actuation into an emitted dose device (EDD; MSP 
Corporation, Shoreview, MN, USA) ﬁ  tted with a 0.1 μm 
polycarbonate ﬁ  lter (Millipore) operated at 30 L/min. The 
suspensions were vortexed for 10 seconds prior to testing 
and a separate actuator was used to prime the suspensions 
3 times. Because of the limit of detection of the EXT700 
method, 10, 5, and 5 actuations were used for each run for 
0.2, 1.0, and 5.0 mg/g suspensions, respectively (n = 6 per 
concentration). One actuation of approximately 1 second 
was used for the 1.0 mg/g suspension with the continuous 
valve (n = 5). A pause of at least 5 seconds between actua-
tions allowed the bottles to be swirled vigorously by hand 
to minimize aggregation and settling. DEP were recovered 
by washing the device, ﬁ  lter, and actuator in ethanol in an 
ultrasonic bath (Vortex Genie 2, Fisher Scientiﬁ  c) and were 
quantiﬁ  ed. The mass of each bottle was recorded before and 
after each experiment to facilitate calculation of the amount 
of propellant used. Expected DEP deposition was calculated 
by multiplying the amount of propellant used by the DEP 
concentration.
Size characterization
Deposition of DEP aerosols as a function of aerodynamic 
diameter was measured using a nonviable cascade impactor 
(NVCI, ThermoAndersen, Smyrna, GA, USA) and an 
electrical low pressure impactor (ELPI; Dekati, Finland). 
The NVCI was operated at a ﬂ  ow of 28.3 l/min with a United 
States Pharmacopeia (USP) sampling inlet. Deposition was 
quantiﬁ  ed by washing the actuator, inlet, and stages in ethanol 
followed by quantiﬁ  cation. 20, 10, and 5 actuations (0.2, 1.0, 
and 5.0 mg/g) were used for each run with metered valves and 
5 actuations were used for each run with a continuous valve 
due to the limit of detection of the quantiﬁ  cation method 
(n = 3 per concentration). The suspensions were primed 
3 times with a separate actuator prior to testing, allowing at 
least 5 seconds between actuations. Bottles were swirled vig-
orously by hand between actuations to prevent aggregation 
and settling. To examine the effect of evaporation time on 
deposition, the same experiments were repeated for bottles 
with metered valves with a 78 cm long, 5 cm diameter tube 
serving as a spacer. The volume of the spacer was approxi-
mately 1.5 L, which allowed approximately 3 seconds of 
added travel time for the aerosol from actuator to inlet.
The ELPI was operated at 30 L/min ﬂ  ow rate with sin-
tered metal collection stages and the ﬁ  lter stage in place. 
The aerosol was introduced to the inlet with and without the 
spacer described above and data was gathered by averaging 
deposition from 5 sequential actuations with swirling in 
between (n = 3 per concentration).
Chemical composition
A method for determining the concentration of 
benzo[a]pyrene (B[a]P) and benzo[k]ﬂ  uoranthene (B[k]F) 
was used to determine the effect of suspension in HFA134a 
on the compounds adsorbed to the surface of the DEP. The 
method was adapted from a dual wavelength ﬂ  uorometric 
detection method (Masaki et al 2005). Fluorescence 
concentration curves for B[a]P and B[k]F dissolved in 
dichloromethane (DCM, 0–500 ng/mL) were made by serial 
dilution (n = 2 per compound). The ﬂ  uorescence of each 
concentration of each compound was read at an emission 
wavelength of 429 nm with excitation wavelengths of 370 
and 395 nm with 5 nm slits (LS50B luminescence spec-
trometer, PerkinElmer). The equations for ﬂ  uorescence as 
function of concentration at each excitation wavelength 
were combined (total ﬂ  uorescence = ﬂ  uorescence from 
B[a]P + ﬂ  uorescence from B[k]F), yielding two equations. 
These equations were solved for the unknowns of B[a]P 
and B[k]F concentrations.
Bulk DEP2 was suspended in DCM in glass vials at 
concentrations of 0.25 to 2.5 mg/ml to determine the concen-
tration of the compounds adsorbed onto DEP (n = 6). DEP2 
suspended in HFA134a (1.0 mg/g) and aged 6 months at 
room temperature or aged less than 1 week at 4 °C (fresh) was 
aerosolized and deposited onto the ﬁ  lter of an EDD (n = 3 per 
condition). The ﬁ  lter was added to a glass vial and suspended 
in DCM (0.1–0.5 mg/mL DEP). All bulk DEP and DEP 
aerosol suspensions were placed in an ultrasonic bath for 
30 minutes to dissolve surface adsorbed compounds. The 
suspensions were then centrifuged at 10,000 g for 15 minutes 
to pellet the suspended particles. Five ml of the supernatant 
were added to a new glass vial and allowed to evaporate at 
room temperature. Solutions of B[a]P and B[k]F in DCM 
(0–500 ng/mL) were made by serial dilution for determine 
the collection efﬁ  ciency of the evaporation and extraction 
methods. Five ml of each concentration of each compound 
were added to glass vials and allowed to evaporate.
The remaining solids from the bulk and aerosol DEP 
and known PAH concentrations were dissolved in 5 ml of 
methanol. The methanol solutions were cleaned with a solid 
phase extraction column (1cc HLB, Waters). For extraction, 
the columns were conditioned with 1 mL DCM and rinsed 
with 1 mL methanol then 1 mL water. After 3 ml of sample 
was added, columns were rinsed with 1 ml of water and the 
compounds were eluted with DCM. The ﬂ  uorescence was International Journal of Nanomedicine 2008:3(4) 439
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read at an emission wavelength of 429 nm with excitation 
wavelengths of 370 and 395 nm, as described above.
Morphology
Small amounts of DEP from the bulk container were 
placed on 13 mm diameter round glass cover slips and 
were examined by SEM (JEOL JSM-6300, JEOL America, 
Peabody, MA, USA). Cover slips were sputter-coated with 
gold-palladium for 60 seconds prior to imaging to improve 
conductivity (Model E-5200, Electron Beam Services, 
Agawan, MA, USA). Aerosols from a 1.0 mg/g DEP 
suspension were deposited on glass cover slips placed on all 
stages of the NVCI operated at 60 l/min and aerosols from 
0.2, 1.0, and 5.0 mg/g DEP suspensions were deposited on 
glass cover slips placed on stages 1, 2, and 3 of the ELPI. 
These cover slips were sputter coated and imaged by SEM 
as described above.
Results and discussion
Quantiﬁ  cation
The turbidity concentration curves were linear over the range 
of 0–60 μg DEP/ml ethanol, with values of the square of 
correlation coefﬁ  cient for linear regression (R2)  0.99. The 
EXT700 values of the 7.95 μg/ml DEP suspension following 
sonication for 30, 60, and 180 seconds were 0.141 ± 0.001, 
0.141 ± 0.001, and 0.144 ± 0.004, respectively. These values 
were not dependant on time after sonication when monitored 
up to 15 minutes (results not shown). This indicated that it 
was acceptable to sonicate for as little as 30 seconds and to 
wait up to 15 minutes following sonication to measure light 
extinction.
Suspension stability
The rates of aggregation and sedimentation were very 
different for the range of suspension concentrations. The 
0.2 and 1.0 mg/g suspensions underwent cluster deposition, 
but at different rates. The lowest concentration (0.2 mg/g) 
showed the smallest extent of visual aggregation. Mixing 
produced uniform, slightly translucent, suspensions. The 
suspensions remained uniform, without individually 
distinguishable aggregates, for the ﬁ  rst 5 minutes. Some 
large ﬂ  occulates were seen by 10 seconds after mixing in 
the 1.0 mg/g suspensions. The majority of these large ﬂ  oc-
culates settled to the bottom of the bottle by 1 minute after 
mixing, leaving the remaining suspension more translucent 
than the 0.2 mg/g suspensions. The 5.0 mg/g suspensions 
underwent collective settling. A ﬂ  occulate formed in the 
entire volume of each bottle within seconds after mixing. 
The ﬂ  occulate height dropped linearly from the top of the 
propellant level for approximately 1 minute, after which the 
height dropped very slowly. The velocity of sedimentation 
was calculated as 0.71 mm/sec by ﬁ  tting a line to the data 
up to 45 seconds (4 data points, R2 = 0.94). The propellant 
above the gelled mass in the 5.0 mg/g suspension appeared 
transparent with few, if any, suspended particles.
The average EXT700 values for the 0.2 and 1.0 mg/ml 
suspensions decreased linearly as a function of the log of 
time from 5 to 80 minutes (R2  0.99). The EXT700 values 
for the 5.0 mg/g suspension did not change signiﬁ  cantly 
over this time period because most particles had sedimented 
with the flocculate previously. A concentration curve 
for DEP in HFA134a could not be produced, but light 
extinction of particles in suspension is directly proportional 
to concentration, provided the particles are of the same 
size (Gebhart 2001). This proportionality indicates that the 
concentration of particles in suspension decreased linearly 
as a function of the log of time following an initial lag time. 
The rate of decrease was greater for the 0.2 mg/g suspension 
because the volume concentration after 5 minutes, and thus 
the aggregation rate and sedimentation rate, was greater. The 
rates of aggregation and sedimentation were much greater in 
the ﬁ  rst few minutes for the 1.0 mg/g suspension, but once the 
large ﬂ  ocs had formed a sediment, the volume of remaining 
suspended particles was less than 0.2 mg/g. The slopes and 
intercepts of linear regressions were recorded for each run of 
each bottle and there were no statistically signiﬁ  cant differ-
ences between bottles or runs (all p  0.05, ANOVA).
Twenty-four hours after mixing, DEP were not detected 
in suspension. The propellant was transparent, but did vary 
slightly in color with DEP concentration. The propellant 
from 0.2 mg/g suspension did not appear different in color 
to propellant without DEP. The propellant from the 1.0 mg/g 
had a slight yellowish tint and that tint was darker in the pro-
pellant from the 5.0 mg/g suspension, indicating dissolution 
of adsorbed compounds in the propellant.
It was clear that when left unstirred, DEP aggregate in 
suspension in HFA134a in concentrations of 0.2 to 5.0 mg/g. 
The rate of this aggregation and the sedimentation of those 
aggregates was dependant on initial concentration. It was also 
clear that the particles de-aggregate reproducibly when the 
same energy was added to the suspension in the form of mix-
ing. The aggregation, settling, and concentration as a function 
of time were reproducible upon mixing. Caking did not occur 
in suspensions left undisturbed up to 6 months. The degree 
of particle aggregation in the ﬁ  rst seconds after mixing the 
suspensions is unknown and the use of these suspensions to International Journal of Nanomedicine 2008:3(4) 440
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create reproducible aerosols requires actuation very soon after 
mixing, but should by reproducible if that time is kept short and 
constant. It was also clear from the color of the liquid follow-
ing complete settling that there are compounds present on the 
DEP that dissolved in the propellant to some extent. The exact 
compounds that dissolve and the extent to which they dissolve 
are unknown, but it should be noted that some dissolution of 
the adsorbed compounds does occur in HFA134a.
Emitted dose
The volume of suspension emitted per actuation and the 
expected DEP deposition calculated from that volume are 
shown in Table 1. The metering valves are reported to emit 
25 μL per actuation, but the three valves used in these experi-
ments delivered an average of 27.9 to 28.9 μL per actuation. 
Approximately 10 times (293 ± 19 μL) the suspension volume 
was delivered from each actuation of the continuous valve.
The mass of DEP recovered from the actuator, the EDD, 
the addition of those (total deposition), and the percent 
recovery (total/expected deposition × 100) are also shown in 
Table 1. Recovery ranged from 96.0% to 97.8 % and there are 
several possible reasons for recovery below 100%. DEP may 
have been incompletely washed from the emitted dose device, 
ﬁ  lter, or actuator because of the small volumes of ethanol 
used. It was also expected that a portion of the DEP mass 
ﬂ  owed through the ﬁ  lter and was not captured because the 
ﬁ  lters used are designed to capture only particles larger than 
100 nm. The data gathered from the ELPI (reported below) 
shows that a signiﬁ  cant fraction of particles in the aerosols 
was smaller than 100 nm. However, the fraction of particles 
smaller than 100 nm was not likely to contain 2%–4% of 
the total mass. It is possible that a portion of the DEP mass 
was aggregated in the bottle to a size that was unable to pass 
into the metering chamber, but this was also unlikely because 
the 5.0 mg/g suspension, in which aggregation occurred the 
fastest, had the highest recovery.
Size characterization: NVCI
The total mass of DEP collected (actuator, inlet, and NVCI) 
per actuation and the mass of DEP collected on the stages of 
the NVCI per actuation are shown in Table 2. The recoveries 
of the aerosols from the 0.2, 1.0, and 5.0 mg/g suspensions 
ﬁ  tted with metered valves were 85.1% ± 1.1%, 84.6% ± 5.3%, 
93.7% ± 2.6%, respectively. The recovery of the aerosol from 
the 1.0 mg/g suspension ﬁ  tted with a continuous valve and 
was 89.7% ± 2.1%. Recovery below 100% of nominal mass 
may be explained as with the emitted dose. The last stage of 
the NVCI has a cutoff diameter of 300 nm, allowing a fraction 
of small particles to pass though without depositing.
DEP deposition on each stage of the NVCI, the sampling 
inlet, and the actuator, as percentages of total expected dose 
for each suspension concentration is shown in Figure 1a. 
The deposition patterns in the NVCI were similar among 
the concentrations, with a slight increase in the deposited 
fraction in the middle size range (stages 3 and 4, 1.8–5.0 μm) 
and a decrease in deposited fraction in the smaller size range 
(stages 6 and 7, 0.3–1.0 μm) as suspension concentration 
increased. The proportion of particle mass deposited in the 
inlet was much greater for the 5.0 mg/g suspension than for 
the 0.2 or 1.0 mg/g suspensions. This may be explained by 
a higher proportion of large particles impacting in the back 
of the inlet for the 5.0 mg/g suspension.
Similar DEP deposition patterns in the NVCI were 
observed when the spacer was used (Figure 1b). There was a 
slight decrease in the mass deposited in the smaller stages for 
the 0.2 mg/g suspension and an increase in the deposition on 
most stages for the 5.0 mg/g suspension. When the deposition 
on each stage is normalized for the width of the particle 
Table 1 Data and calculations from the emitted dose device (mean ± SD, n = 6)
Product Information 25 μL Metered valve Continuous valve
0.2 mg/g 1.0 mg/g 5.0 mg/g 1.0 mg/g
Actuations per run 10 5 5 1
Suspension/actuation (μL) 27.9 ± 0.2 28.9 ± 0.2 28.2 ± 0.1 293 ± 19
Expected diesel exhaust 
particles dose (μg)
67.5 175 853 354 ± 23
Actuator deposition (μg) 18 ± 1 43 ± 2 186 ± 1 102 ± 11
Device deposition (μg) 47 ± 1 125 ± 5 648 ± 7 239 ± 18
Total deposition (μg) 65 ± 1 168 ± 6 834 ± 6 341 ± 23
Deposition per actuation 6.5 ± 0.1 33.6 ± 1.2 166.8 ± 1.2 341 ± 23
Percent recovery 96.3 ± 1.5 96.0 ± 3.4 97.8 ± 0.7 96.4 ± 1.3International Journal of Nanomedicine 2008:3(4) 441
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size range (in logarithms) collected on each stage, creating 
histograms similar to particle size distributions (Figure 2) 
these differences can be easily observed. The particle size 
distributions for each concentration were multimodal with 
primary maxima 2 μm (Mass Mode 1, MM1) and secondary 
maxima in the 5–6 μm range (Mass Mode 2, MM2). 
There were slight variations in the location of the maxima, 
which are discussed in conjunction with the ELPI data below. 
The location of these maxima better describe the distributions 
than estimation of mass median aerodynamic diameter. 
Calculations of geometric standard deviation could only be 
performed if the distributions were log-normal with a single 
Table 2 Total mass recovered, mass recovered from the stages of the nonviable cascade impactor (NVCI, n = 3), and number deposition 
on the stages of the electronic low pressure impactor (ELPI, n = 5) per actuation (mean ± SD)
Measured particle property Spacer Diesel exhaust particles concentration (mg/g)
0 0.2 1.0 5.0
Total mass/actuation (μg) No NA 5.7 ± 0.1 29.6 ± 1.9 159.7 ± 4.4
NVCI mass/actuation (μg) No NA 3.7 ± 0.1 19.2 ± 0.7 76.2 ± 3.7
NVCI mass/actuation (μg) Yes NA 3.1 ± 0.1 20.4 ± 1.2 90.1 ± 3.5
Number/actuation (× 108) No 19.3 ± 3.7 44.7 ± 8.6 58.4 ± 2.9 53.8 ± 7.6
Number/actuation (× 108) Yes 3.7 ± 0.4 20.9 ± 0.7 31.3 ± 0.8 30.3 ± 1.3
Figure 1 Percentage of expected total diesel exhaust particle dose deposited per actuation in actuator, sampling inlet, and nonviable cascade impactor (a) without and (b) 
with the spacer (mean ± SD, n = 3). 
Note: *Actuator and inlet deposition were not calculated when the spacer was used.
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Figure 2 Particle size distributions by mass of diesel exhaust particle aerosols deposited in the nonviable cascade impactor with and without the spacer (mean, n = 3).   Two 
apparent size modes, Mass Mode 1 (MM1) and Mass Mode 2 (MM2), are labeled.
mode. Since this was not the case, this calculation was not 
performed.
The particle size distribution of the aerosol from the 
1.0 mg/g suspension with the continuous valve (Figure 2d) 
was similar to the distribution of the aerosol from the 1.0 mg/g 
suspension with the metered valve (Figure 2b). There was an 
increase (18.4 ± 3.4% compared to 5.6 ± 2.4%) in fractional 
inlet deposition for the continuous valve that may have been 
due to a change in plume shape resulting from a change in 
actuation duration.
Size characterization: ELPI
The total numbers of particles detected by the ELPI for each 
DEP suspension ﬁ  tted with a metered valve are shown in 
Table 2. A statistically smaller number of particles deposited 
from the aerosol of the 0.2 mg/g suspension than from the other 
DEP aerosols with and without a spacer (p  0.05, ANOVA). 
This decrease may be explained by a decrease in average par-
ticle size, as is discussed below, and an associated increase in 
number of particles small enough to pass through the ﬁ  lter and 
remain uncounted. The presence of droplets without DEP, also 
discussed below, may have also contributed to the decrease.
The total particle numbers for the aerosol from 
the propellant alone were much smaller than the other 
formulations, but were greater than zero. This indicates that 
the propellant had not completely evaporated by the time the 
aerosol reached the ELPI or that there was a contaminant, 
such as dissolved water, remaining. Water is somewhat 
soluble in HFA134a (Atkins and Crowder 2004) and could 
have remained after the propellant had evaporated.
The number of particles that deposited per actuation 
on each stage of the ELPI for each formulation with and 
without use of the spacer is shown in Figure 3. The pattern 
of deposition, like for mass deposition in the NVCI, is similar 
for all the formulations. For each formulation, the largest 
number of particles deposited on the ﬁ  lter stage (7–25 nm), 
with a general trend of decreasing particle deposition in the 
higher stages. The use of the spacer decreased the average 
number and standard deviation of particles counted per 
actuation on each stage for all formulations. These decreases 
in deposition may have been due to collection of particles 
in the spacer, particularly in the ﬂ  ow transition regions. 
Although if spacer deposition did occur, it was either limited 
to smaller particles that did not constitute much of the particle International Journal of Nanomedicine 2008:3(4) 443
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mass (not seen in the NVCI data) or was confounded with 
the change in deposition in the inlet. The mass deposited in 
the NVCI was lower for 0.2 mg/g, approximately the same 
for 1.0 mg/g, and higher for 5.0 mg/g with the addition of the 
spacer. It was not easy to discern if the decreases in deposition 
in the ELPI were dependant on particle size because of the 
large standard deviations in the upper stages.
The decrease in number may also be explained by 
evaporation of propellant and/or other molecules. There 
was an approximately 50% decrease in deposition for the 
suspension formulations on each stage and an 80% decrease 
for the propellant only formulation. This difference cannot 
be explained with deposition in the spacer. If the aerosol 
from the propellant only formulation contained particles of 
water, some may have evaporated to a size smaller than was 
detectable by the ELPI.
The number deposition on each stage was normalized 
for the width of the particle size range (in logarithms) 
collected on each stage, creating histograms similar to 
particle size distributions (Figure 4). The number distri-
butions of the suspension formulation were similar and 
appear to be multimodal with primary maxima 100 nm 
(Number Mode 1, NM1) and secondary maxima at 
approximately 300 nm (Number Mode 2, NM2). These 
distributions are discussed in conjunction with the mass 
distributions below.
Size characterization: Discussion
The mass and number-based particle size distributions 
appear to be bimodal, but when taken together indicate a 
probable trimodal aerosol particle size distribution. There 
were large numbers of nanoparicles (NM1) that would not 
be seen in the data from the NVCI because particles in this 
size range are too small to deposit in the device and contain 
very little mass. NM2 likely represents the same particle 
mode that is represented by MM1. The shift in location 
on the particle diameter axis from NM2 (∼0.2–0.3 μm) to 
MM1 (0.5–1.5 μm) is typical of particle size distributions 
based on number and mass [mass ∝ (number × diameter3)]. 
The number of particles contained in MM2 was likely too 
small for that mode to be seen in the ELPI data. The size 
distributions of suspension MDI aerosols are functions 
of the initial droplet sizes and the number of suspended 
particles and dissolved material that each droplet contains. 
If the aerosol particle size distribution was trimodal, the 
initial droplet distribution was likely trimodal. A diagram 
of the potential size distribution of droplets and final 
aerosol particles is shown in Figure 5. It has been shown 
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previously that some HFA134a pressurized metered dose 
inhaler aerosols have multi-modal droplet size distributions 
(Smyth and Hickey 2003).
The initial droplet distribution shown in Figure 5 
would lead to differences in the locations of the various 
modes on the particle size axis for the different suspension 
concentrations. The number of suspended particles in each 
droplet is dependant on the size of the primary particles, 
the concentration of those particles in suspension, and the 
degree of aggregation at the time of aerosolization. In the 
case of the DEP suspensions described above, only the 
concentration was known. If no aggregation is assumed, 
each droplet would contain a number of particles and mass 
of dissolved material dependant on DEP concentration. 
The diameter of an aerosol particle is proportional to the 
cubed root of its volume and, therefore, it is proportional 
to the cubed root of initial DEP concentration. Each par-
ticle in the aerosol from the 5.0 mg/g aerosol would have a 
diameter ∼1.7 (cube root of 5) times larger than from the 1.0 
mg/g suspension ∼2.9 (cubed root of 25) times larger than 
from the 0.2 mg/g suspension. This phenomenon is evident 
in MM1 (Figure 2). As the concentration increases, the peak 
of that mode appears to shift to the right on the order of 1.7 
and 2.9 times. This shift is not as clear for MM2 and NM1, 
but may be present.
If aggregation did occur to any signiﬁ  cant extent in 
the propellant prior to droplet formation, an initial droplet 
size distribution with only one or two modes could have 
yielded three or more ﬁ  nal aerosol particle size modes. In 
this scenario, a droplet of a particular size might or might 
not contain an aggregate. Those containing aggregates 
would have a ﬁ  nal particle size different than those that did 
not, yielding two different particle size modes from one 
initial droplet size. This seems unlikely, however, because 
aggregation rates are dependant on particle concentration 
and differences in aggregation rates would be evident in the 
number particle size distributions.
Morphological characterization
SEM images of DEP can be seen in Figure 6. The particles 
were highly aggregated. The primary particles are not distinct, 
but give the powders a ﬂ  uffy appearance. SEM images of 
DEP deposited from a 1.0 mg/g suspension on stages 3–6 of 
the NVCI (60 L/min) are shown in Figure 7 (particles from 
the other concentrations looked very similar and are not 
shown). The particles appear to be roughly spherical aggre-
gates with diameters dependant on the stage on which they 
deposited. As with the bulk powder, the primary particles 
in the aggregates cannot be distinguished, but give a ﬂ  uffy 
appearance. Images of DEP deposited from a 1.0 mg/g 
suspension on stage 2 of the ELPI are shown in Figure 8 
(particles deposited on stages 1 and 3, and from the other 
concentrations looked very similar and are not shown). The 
particles on this stage of the ELPI (32 nm cutoff) are gener-
ally smaller and with a wider range of sizes and shapes, than 
those seen in the lowest stage of the NVCI (200 nm cutoff 
for stage 6). The physical diameters of the DEP deposited 
on stage 2 of the ELPI varies from 50 nm to ∼1 μm, which 
is much larger than the aerodynamic diameter range corre-
sponding to that stage (32–51 nm). This discrepancy may be 
due to the aggregation of multiple aerosol particles after depo-
sition, but it is impossible to make that determination. It is 
also possible that a low density and nonspherical shape gave 
the particles an aerodynamic diameter much smaller than their 
physical diameter, although it is unlikely that a particle with 
a physical dimension of 1 μm had an aerodynamic diameter 
20-fold less. Poor impactor efﬁ  ciency and/or reintrainment 
of particles from the upper stages may have also contributed 
to the deposition of large particles on this stage.
Chemical composition
The concentration curves for B[a]P and B[k]F were linear 
for both wavelengths over the concentration range of 
0–125 ng/ml (R2  0.99 for all lines). The equations for 
these lines and average values are shown in Table 3. The 
combination of these equation yields two unique equations 
used to calculate the amount of B[a]P and B[k]F dissolved 
in the DCM of sonicated DEP suspensions:
  Conc
Fl Conc
BaP
BkF
[]
[] .
.
=
−⋅ 370 05 7
13 9
  (1)
  Conc
Fl Fl
BkF []
..
.
=
⋅−⋅ 13 9 04 7
07 2
395 370   (2)
The recovery for the known PAH concentrations from 
the solid phase extraction columns was 92%–98% for B[a]P 
and 84%–92% for B[k]F over the range of concentrations 
and was not dependant on concentration. The calculated 
PAH concentrations as functions of the DEP concentration 
are shown in Figure 9. This ﬁ  gure also shows there were no 
obvious differences in the amount of PAH dissolved from 
bulk DEP or aged or fresh DEP aerosol. The relationship 
appears to be linear at low concentration, as expected, but 
not at the highest (∼1.2 mg/mL) DEP concentration. This 
nonlinearity was likely due to a saturation of organic com-
pounds in the DCM at high DEP concentrations.International Journal of Nanomedicine 2008:3(4) 446
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Figure 6 Scanning electron micrographs of diesel exhaust particles in bulk at (a) 1000X and (b) 10000X.
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Figure 7 Scanning electron micrographs of 1.0 mg/g propellant suspension diesel exhaust particle aerosols deposited on stage 3–6 of the nonviable cascade impactor operated 
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Figure 8 Scanning electron micrographs of diesel exhaust particles (DEP) deposited on a glass cover slip placed on stage 2 (32–51 nm range) of the electronic low pressure 
impactor following 15 actuations of a 1.0 mg/g DEP in HFA134a suspension at (a) 5000X and (b) 30000X.
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Conclusions
The aim of the work described above was to generate 
and characterize experimental DEP aerosols relevant to 
atmospheric DEP for use in animal or in vitro toxicology 
studies. As stated in the introduction, DEP exist in the 
atmosphere in three overlapping particle size modes ranging 
from several nm to several μm. DEP aerosols were created 
by a propellant suspension method that had aerodynamic 
particle size distributions similar to atmospheric DEP. SEM 
images indicate that the aerosol particles that were generated 
were more highly aggregated than the fractal-like particles 
seen in the atmosphere. The composition of the smallest 
nanoparticle mode (NM1) was difﬁ  cult to determine, but 
was probably a combination of aggregates of a small number 
of solid, elemental carbon particles and particles containing 
only compounds that dissolved from the DEP surface and 
remained following propellant evaporation.
The method of generating DEP aerosols by suspension 
in propellant could be optimized in terms of particle shape 
and size distribution. Altering the suspension concentration, 
actuator design, or propellant used could produce aerosols 
with different size and shape characteristics. Addition of 
surfactant to MDI formulations could control aggregation 
or physical stability of the suspensions (Vervaet and Byron 
1999). Addition of chemicals of interest to the suspension 
could allow study of the effects of concentration of speciﬁ  c 
compounds in DEP.
The ease of use and cost beneﬁ  ts of generating of DEP 
aerosols from a bulk source as an alternative to current 
laboratory DEP aerosol exposure methods are apparent. 
There is also the potential to increase the reproducibility of 
exposure. There are a number of factors that inﬂ  uence the size 
and chemical concentration of DEP aerosols generated from 
engines in the laboratory environment including engine type, 
operating conditions, fuel type, and post-combustion condi-
tions. It is difﬁ  cult to tightly control all of these parameters 
and, thus, to ensure that a reproducible DEP aerosol is pro-
duced for inter-laboratory comparison of data. DEP aerosols 
generated from a standardized bulk source would be much 
easier to be made reproducible.
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